“…There are some PA isomers recommended to be monitored by the European Commission Regulation 2020/2040, e.g., indicine, echinatine, rinderine (possible coelution with lycopsamine/intermedine), indicine- N -oxide, echinatine- N -oxide, rinderine- N -oxide (possible coelution with lycopsamine- N -oxide/intermedine- N -oxide), integerrimine (possible coelution with senecivernine/senecionine), integerrimine- N -oxide (possible coelution with senecivernine- N -oxide/senecionine- N -oxide), heliosupine (possible coelution with echimidine), heliosupine- N -oxide (possible coelution with echimidine- N -oxide), spartioidine (possible coelution with seneciphylline), spartioidine- N -oxide (possible coelution with seneciphylline- N -oxide), usaramine (possible coelution with retrorsine), and usaramine N -oxide (possible coelution with retrorsine N -oxide) [ 47 ]. Chromatographic resolution is fundamental for the differentiation of isomeric PAs such as intermedine, indicine, lycopsamine, rinderine, and echinatine ( m / z 300) and their N -oxides ( m / z 316) as well as integerrimine, senecionine, and senecivernine ( m / z 336) and their N -oxides ( m / z 352), [ 100 ]. Klein, et al [ 100 ] applied different acidic and alkaline mobile phases and succeeded to differentiate between some of the PA isomers, especially when alkaline conditions were applied.…”